Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
1,016
Views
0
CrossRef citations to date
0
Altmetric
Original research
PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis
Eun-Jin Goa Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Korea;b Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of KoreaView further author information
, Hannah Yanga Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Korea;b Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Koreahttps://orcid.org/0000-0003-2252-7041View further author information
, Seung Joon Leea Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Korea;b Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of KoreaView further author information
, Hyun Gul Yangc Panolos Bioscience, Inc, Hwaseong-si, Republic of KoreaView further author information
, Jin A. Shinc Panolos Bioscience, Inc, Hwaseong-si, Republic of KoreaView further author information
, Won Suk Leea Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Korea;b Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of KoreaView further author information
, Hye Seong Limc Panolos Bioscience, Inc, Hwaseong-si, Republic of KoreaView further author information
, Hong Jae Chona Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Korea;b Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-6979-5812View further author information
& https://orcid.org/0000-0002-6979-5812View further author information
Chan Kima Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of Korea;b Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi-do, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0001-9780-6155View further author information
show allhttps://orcid.org/0000-0001-9780-6155View further author information
Article: 2259212
|
Received 11 May 2023, Accepted 11 Sep 2023, Published online: 20 Sep 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.